Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, et al. Markers of inflammation and cardiovascular disease. Circulation. 2003;107(3):499–511.

Article  PubMed  Google Scholar 

Li J, Lee DH, Hu J, Tabung FK, Li Y, Bhupathiraju SN, et al. Dietary inflammatory potential and risk of cardiovascular disease among men and women in the U.S. J Am Coll Cardiol. 2020;76(19):2181–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luvián-Morales J, Varela-Castillo FO, Flores-Cisneros L, Cetina-Pérez L, Castro-Eguiluz D. Functional foods modulating inflammation and metabolism in chronic diseases: a systematic review. Crit Rev Food Sci Nutr. 2022;62(16):4371–92.

Article  PubMed  Google Scholar 

Hu FB. Dietary pattern analysis: a new direction in nutritional epidemiology. Curr Opin Lipidol. 2002;13(1):3–9.

Article  CAS  PubMed  Google Scholar 

Reedy J, Krebs-Smith SM, Miller PE, Liese AD, Kahle LL, Park Y, et al. Higher diet quality is associated with decreased risk of all-cause, cardiovascular disease, and cancer mortality among older adults. J Nutr. 2014;144(6):881–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luan Y-y, Yao Y-m. The Clinical Significance and Potential Role of C-Reactive Protein in Chronic Inflammatory and Neurodegenerative Diseases. Front Immunol. 2018;9.

Banait T, Wanjari A, Danade V, Banait S, Jain J. Role of high-sensitivity C-reactive protein (Hs-CRP) in non-communicable diseases: a review. Cureus. 2022;14(10): e30225.

PubMed  PubMed Central  Google Scholar 

Bower JK, Lazo M, Juraschek SP, Selvin E. Within-person variability in high-sensitivity C-reactive protein. Arch Intern Med. 2012;172(19):1519–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

English CJ, Lohning AE, Mayr HL, Jones M, Reidlinger DP. Interrelationships among platelet-activating factor and lipoprotein-associated phospholipase A2 activity and traditional cardiovascular risk factors. BioFactors. 2022;n/a(n/a).

Handley DA, Arbeeny CM, Lee ML, Van Valen RG, Saunders RN. Effect of platelet activating factor on endothelial permeability to plasma macromolecules. Immunopharmacology. 1984;8(3):137–42.

Article  CAS  PubMed  Google Scholar 

Satoh K, Imaizumi T, Yoshida H, Hiramoto M, Takamatsu S. Increased levels of blood platelet-activating factor (PAF) and PAF-like lipids in patients with ischemic stroke. Acta Neurol Scand. 1992;85(2):122–7.

Article  CAS  PubMed  Google Scholar 

Chen H, Zheng P, Zhu H, Zhu J, Zhao L, El Mokhtari NE, et al. Platelet-activating factor levels of serum and gingival crevicular fluid in nonsmoking patients with periodontitis and/or coronary heart disease. Clin Oral Investig. 2010;14(6):629–36.

Article  PubMed  Google Scholar 

Zheng G-H, Xiong S-Q, Mei L-J, Chen H-Y, Wang T, Chu J-F. Elevated plasma platelet activating factor, platelet activating factor acetylhydrolase levels and risk of coronary heart disease or blood stasis syndrome of coronary heart disease in chinese: a case control study. Inflammation. 2012;35(4):1419–28.

Article  CAS  PubMed  Google Scholar 

Detopoulou P, Fragopoulou E, Nomikos T, Antonopoulou S, Kotroyiannis I, Vassiliadou C, et al. Baseline and 6-Week follow-up levels of PAF and activity of its metabolic enzymes in patients with heart failure and healthy volunteers–a pilot study. Angiology. 2013;64(7):522–8.

Article  CAS  PubMed  Google Scholar 

Corson MA, Jones PH, Davidson MH. Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker. Am J Cardiol. 2008;101(12a):41f–50f.

Article  CAS  PubMed  Google Scholar 

Dennis EA. Allosteric regulation by membranes and hydrophobic subsites in phospholipase A(2) enzymes determine their substrate specificity. J Biol Chem. 2022;298(5):101873.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cojocaru M, Cojocaru IM, Silosi I. Lipoprotein-associated phospholipase A2 as a predictive biomarker of sub-clinical inflammation in cardiovascular diseases. Maedica (Buchar). 2010;5(1):51–5.

Google Scholar 

Garza CA, Montori VM, McConnell JP, Somers VK, Kullo IJ, Lopez-Jimenez F. Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review. Mayo Clin Proc. 2007;82(2):159–65.

Article  CAS  PubMed  Google Scholar 

Chung H, Kwon HM, Kim J-Y, Yoon Y-W, Rhee J, Choi E-Y, et al. Lipoprotein-associated phospholipase A2 is related to plaque stability and is a potential biomarker for acute coronary syndrome. Yonsei Med J. 2014;55(6):1507–15.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu G, Liu D, Tong H, Huang W, Hu Y, Huang Y. Lipoprotein-associated phospholipase A2 activity and mass as independent risk factor of stroke: a meta-analysis. Biomed Res Int. 2019;2019:1–11.

Article  CAS  Google Scholar 

Perrot N, Thériault S, Rigade S, Chen HY, Dina C, Martinsson A, et al. Lipoprotein-associated phospholipase A2 activity, genetics and calcific aortic valve stenosis in humans. Heart. 2020;106(18):1407–12.

Article  CAS  PubMed  Google Scholar 

Schwingshackl L, Hoffmann G. Mediterranean dietary pattern, inflammation and endothelial function: a systematic review and meta-analysis of intervention trials. Nutr Metab Cardiovasc Dis. 2014;24(9):929–39.

Article  CAS  PubMed  Google Scholar 

Soltani S, Chitsazi MJ, Salehi-Abargouei A. The effect of dietary approaches to stop hypertension (DASH) on serum inflammatory markers: A systematic review and meta-analysis of randomized trials. Clin Nutr. 2018;37(2):542–50.

Article  CAS  PubMed  Google Scholar 

Menzel J, Jabakhanji A, Biemann R, Mai K, Abraham K, Weikert C. Systematic review and meta-analysis of the associations of vegan and vegetarian diets with inflammatory biomarkers. Sci Rep. 2020;10(1):21736.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reidlinger DP, Darzi J, Hall WL, Seed PT, Chowienczyk PJ, Sanders TA. How effective are current dietary guidelines for cardiovascular disease prevention in healthy middle-aged and older men and women? A randomized controlled trial. Am J Clin Nutr. 2015;101(5):922–30.

Article  CAS  PubMed  Google Scholar 

English CJ, Mayr HL, Lohning AE, Reidlinger DP. The association between dietary patterns and the novel inflammatory markers platelet-activating factor and lipoprotein-associated phospholipase A2: a systematic review. Nutr Rev. 2022;80(6):1371–91.

Article  PubMed  PubMed Central  Google Scholar 

Packard CJ, O’Reilly DS, Caslake MJ, McMahon AD, Ford I, Cooney J, et al. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med. 2000;343(16):1148–55.

Article  CAS  PubMed  Google Scholar 

Oei HH, van der Meer IM, Hofman A, Koudstaal PJ, Stijnen T, Breteler MM, et al. Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study. Circulation. 2005;111(5):570–5.

Article  CAS  PubMed  Google Scholar 

Persson M, Hedblad B, Nelson JJ, Berglund G. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects. Arterioscler Thromb Vasc Biol. 2007;27(6):1411–6.

Article  CAS  PubMed  Google Scholar 

Yokote K, Suzuki A, Li Y, Matsuoka N, Teramoto T. Pharmacokinetics and exploratory efficacy biomarkers of bococizumab, an anti-PCSK9 monoclonal antibody, in hypercholesterolemic Japanese subjects. Int J Clin Pharmacol Ther. 2019;57(12):575–89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gajos G, Zalewski J, Mostowik M, Konduracka E, Nessler J, Undas A. Polyunsaturated omega-3 fatty acids reduce lipoprotein-associated phospholipase A(2) in patients with stable angina. Nutr Metab Cardiovasc Dis. 2014;24(4):434–9.

Article  CAS  PubMed  Google Scholar 

Stojanovic M, Radenkovic M. Omega-3 fatty acids are capable to decrease the lipoprotein-associated phospholipase A2 blood level. Atherosclerosis. 2018;275: e237.

Article  Google Scholar 

Brilakis ES, Khera A, McGuire DK, See R, Banerjee S, Murphy SA, et al. Influence of race and sex on lipoprotein-associated phospholipase A2 levels: observations from the Dallas Heart Study. Atherosclerosis. 2008;199(1):110–5.

Article  CAS  PubMed  Google Scholar 

Enkhmaa B, Anuurad E, Zhang W, Pearson TA, Berglund L. Association of Lp-PLA(2) activity with allele-specific Lp(a) levels in a bi-ethnic population. Atherosclerosis. 2010;211(2):526–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee KK, Fortmann SP, Varady A, Fair JM, Go AS, Quertermous T, et al. Racial variation in lipoprotein-associated phospholipase A2 in older adults. BMC Cardiovasc Disord. 2011;11(1):38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Detopoulou P, Nomikos T, Fragopoulou E, Panagiotakos DB, Pitsavos C, Stefanadis C, et al. Lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, platelet-activating factor acetylhydrolase (PAF-AH) in leukocytes and body composition in healthy adults. Lipids Health Dis. 2009;8(1):19.

Article  PubMed  PubMed Central